Causal inference between immune cells and glioblastoma: a bidirectional Mendelian randomization study
2025

Causal Links Between Immune Cells and Glioblastoma

Sample size: 731 publication Evidence: high

Author Information

Author(s): Hou Shiqiang, Jin Chunjing, Shi Beitian, Chen Yinan, Lin Ning

Primary Institution: The Affiliated Chuzhou Hospital of Anhui Medical University

Hypothesis

This study aimed to observe the causal inference between glioblastoma (GBM) and various immune cells using bidirectional Mendelian randomization analysis.

Conclusion

The study confirmed the causal inference between 16 different immunophenotypes and GBM, providing a foundation for future immunological research and immunotherapy.

Supporting Evidence

  • Seven immunophenotypes were found to be associated with GBM risk.
  • GBM was found to be strongly associated with nine immunophenotypes.
  • The study utilized Inverse Variance Weighted and False Discovery Rate methods for analysis.
  • Results were validated through sensitivity analysis to ensure reliability.

Takeaway

Researchers found that certain immune cells can affect glioblastoma, a type of brain cancer, and vice versa, which helps us understand how to treat it better.

Methodology

The study used bidirectional Mendelian randomization analysis with data from the GWAS database, analyzing 731 immunophenotypes.

Potential Biases

Potential biases may arise from the reliance on publicly available data and the assumptions inherent in Mendelian randomization.

Limitations

The study's results may be limited by the single source of GBM data and lack of detailed patient information for stratified analysis.

Statistical Information

P-Value

p<0.05

Confidence Interval

95% CI

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.7150/jca.100519

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication